Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:36PM EDT. Market open.
| Previous close | 40.28 |
| Open | 40.13 |
| Bid | 40.94 x 800 |
| Ask | 40.95 x 1400 |
| Day's range | 38.16 - 41.29 |
| 52-week range | 34.88 - 277.80 |
| Volume | |
| Avg. volume | 7,491,275 |
| Market cap | 3.102B |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Editor's pickYahoo Finance
Novavax does not have a forecast for U.S. orders in 2022: CEO Erck
Novavax missed Wall Street expectations but remains optimistic about the fourth quarter and 2023.
- Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.
- Motley Fool
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026
A more than 30% peak decline in the Nasdaq Composite is allowing investors to buy these phenomenal stocks at bargain-basement prices.
© 2022 Yahoo. All rights reserved.
